An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases

por Chou, Cheng-Wei, Huang, Yu-Kai, Kuo, Ting-Ting, Liu, Jing-Pei, Sher, Yuh-Pyng
Publicado 2020

Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells

por Ko, Pin-Hao, Lenka, Govinda, Chen, Yu-An, Chuang, Eric Y., Tsai, Mong-Hsun, Sher, Yuh-Pyng, Lai, Liang-Chuan
Publicado 2019

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

por Chou, Cheng-Wei, Lin, Ching-Heng, Hsiao, Tzu-Hung, Lo, Chia-Chien, Hsieh, Chih-Ying, Huang, Cheng-Chung, Sher, Yuh-Pyng
Publicado 2019

Cancer Targeted Gene Therapy of BikDD Inhibits Orthotopic Lung Cancer Growth and Improves Long-term Survival

por Sher, Yuh-Pyng, Tzeng, Tz-Fei, Kan, Shu-Fen, Hsu, Jennifer, Xie, Xiaoming, Han, Zhenbo, Lin, Wen-Chuan, Li, Long-Yuan, Hung, Mien-Chie
Publicado 2009

Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation

por Lai, Liang-Chuan, Su, Yi-Yu, Chen, Kuo-Chih, Tsai, Mong-Hsun, Sher, Yuh-Pyng, Lu, Tzu-Pin, Lee, Chien-Yueh, Chuang, Eric Y.
Publicado 2011

ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells

por Sher, Yuh-Pyng, Wang, Li-Ju, Chuang, Li-Ling, Tsai, Mong-Hsun, Kuo, Ting-Ting, Huang, Cheng-Chung, Chuang, Eric Y., Lai, Liang-Chuan
Publicado 2014

Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy

por Lin, Min-Han, Shen, Kuan-Yin, Liu, Bing-Sin, Chen, I-Hua, Sher, Yuh-Pyng, Tseng, Guan-Chin, Liu, Shih-Jen, Sung, Wang-Chou
Publicado 2019

A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity

por Sher, Yuh-Pyng, Chai, Kit Man, Chen, Wen-Ching, Shen, Kuan-Yin, Chen, I-Hua, Lee, Ming-Hui, Chiu, Fang-Feng, Liu, Shih-Jen
Publicado 2020

A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model

por Sher, Yuh-Pyng, Lin, Su-I, Chen, I-Hua, Liu, Hsin-Yu, Lin, Chen-Yuan, Chiang, I-Ping, Roffler, Steve, Chen, Hsin-Wei, Liu, Shih-Jen
Publicado 2015

A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression

por Melano, Ivonne, Cheng, Wei-Chung, Kuo, Li-Lan, Liu, Yuag-Meng, Chou, Yu Chi, Hung, Mien-Chie, Lai, Michael M. C., Sher, Yuh-Pyng, Su, Wen-Chi
Publicado 2023

MicroRNA-769-3p Down-regulates NDRG1 and Enhances Apoptosis in MCF-7 Cells During Reoxygenation

por Luo, En-Ching, Chang, Ya-Chu, Sher, Yuh-Pyng, Huang, Wei-Yung, Chuang, Li-Ling, Chiu, Yu-Chiao, Tsai, Mong-Hsun, Chuang, Eric Y., Lai, Liang-Chuan
Publicado 2014

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis

por Chiu, Kuo-Liang, Kuo, Ting-Ting, Kuok, Qian-Yu, Lin, Yu-Sen, Hua, Chung-Hung, Lin, Chen-Yuan, Su, Pei-Yuan, Lai, Liang-Chuan, Sher, Yuh-Pyng
Publicado 2015

EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

por Fan, Chi-Chen, Tsai, Sheng-Ta, Lin, Chen-Yuan, Chang, Ling-Chu, Yang, Juan-Cheng, Chen, Guan‐Yu, Sher, Yuh-Pyng, Wang, Shao-Chun, Hsiao, Michael, Chang, Wei‐Chao
Publicado 2020

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma

por Liu, Chien-Ming, Chiu, Kuo-Liang, Chen, Tzu-Sheng, Chang, Shang-Miao, Yang, Shu-Yun, Chen, Li-Hsiou, Ni, Yung-Lun, Sher, Yuh-Pyng, Yu, Sung-Liang, Ma, Wen-Lung
Publicado 2015

Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells

por Li, En-Yu, Huang, Wei-Yung, Chang, Ya-Chu, Tsai, Mong-Hsun, Chuang, Eric Y., Kuok, Qian-Yu, Bai, Shih-Ting, Chao, Lo-Yun, Sher, Yuh-Pyng, Lai, Liang-Chuan
Publicado 2016

EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma

por Fan, Chi-Chen, Cheng, Wei-Chung, Huang, Yu-Chuen, Sher, Yuh-Pyng, Liou, Nia-Jhen, Chien, Yu-Chuan, Lin, Pei-Shan, Lin, Pei-Syuan, Chen, Chung-Hsuan, Chang, Wei-Chao
Publicado 2017

Publisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma

por Fan, Chi-Chen, Cheng, Wei-Chung, Huang, Yu-Chuen, Sher, Yuh-Pyng, Liou, Nia-Jhen, Chien, Yu-Chuan, Lin, Pei-Shan, Lin, Pei-Syuan, Chen, Chung-Hsuan, Chang, Wei-Chao
Publicado 2018

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment

por Wong, Sze‐Ching, Yeh, Chun‐Chieh, Zhang, Xun‐Yu, Hsieh, Chih‐Ying, Lo, Chia‐Chien, Kuo, Ting‐Ting, Lin, Ching‐Chan, Chao, Chih‐Hua, Liu, Jing‐Pei, Chang, Ling‐Chu, Wang, Lu‐Hai, Sher, Yuh‐Pyng
Publicado 2023

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis

por Chiu, Kuo-Liang, Lin, Yu-Sen, Kuo, Ting-Ting, Lo, Chia-Chien, Huang, Yu-Kai, Chang, Hsien-Fang, Chuang, Eric Y., Lin, Ching-Chan, Cheng, Wei-Chung, Liu, Yen-Nien, Lai, Liang-Chuan, Sher, Yuh-Pyng
Publicado 2017

Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

por Liu, Shu-Hsuan, Hsu, Kai-Wen, Lai, Yo-Liang, Lin, Yu-Feng, Chen, Fang-Hsin, Peng, Pei-Hwa, Lin, Li-Jie, Wu, Heng-Hsiung, Li, Chia-Yang, Wang, Shu-Chi, Wu, Min-Zu, Sher, Yuh-Pyng, Cheng, Wei-Chung
Publicado 2021